v3.26.1
Fair Value (Tables)
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value
The following table presents information about the Company’s financial instruments measured at fair value as of March 31, 2026 and December 31, 2025, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands).
Quoted Prices in Active Markets
Level 1		Significant Other Observable Inputs
Level 2		Significant Unobservable Inputs
Level 3		Total
March 31, 2026
Derivative assets, at fair value (non-designated)$— $636 $— $636 
Derivative assets, at fair value (designated)— 759 — 759 
Total $— $1,395 $— $1,395 
December 31, 2025
Derivative assets, at fair value (non-designated)$— $569 $— $569 
Derivative liabilities, at fair value (designated)— (188)— (188)
Total $— $381 $— $381 
Schedule of Fair Value by Balance Sheet
The fair values of the Company’s remaining financial instruments that are not reported at fair value on the consolidated balance sheets are as follows (dollars in thousands):
March 31, 2026December 31, 2025
LevelCarrying amount Fair value
Carrying amount
Fair value
Gross mortgage notes payable and mortgage premium and discounts3$374,185 $358,329 $374,382 $362,947 
Fannie Mae Secured Debt3333,296 333,949 334,739 335,158 
Unsecured term loan3150,000 148,581 150,000 148,496 
Unsecured revolving credit facility3186,000 184,240 186,000 184,135 
Total debt3$1,043,481 $1,025,099 $1,045,121 $1,030,736